METHODS OF USING AND COMPOSITIONS CONTAINING DULAGLUTIDE

To provide methods of using new doses of dulaglutide for treating type 2 diabetes.SOLUTION: The present invention provides a method of improving glycemic control in a subject having type 2 diabetes (T2D) and in need of additional glycemic control, comprising: a) identifying a subject having T2D and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ANDREW GORDON WERNER, DAVID BRADLEY WOODWARD, LAI SAN THAM, DAVID ANDREW COX, ZVONKO MILICEVIC
Format:	Patent
Sprache:	eng ; jpn
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To provide methods of using new doses of dulaglutide for treating type 2 diabetes.SOLUTION: The present invention provides a method of improving glycemic control in a subject having type 2 diabetes (T2D) and in need of additional glycemic control, comprising: a) identifying a subject having T2D and in need of further glycemic control; b) administering to the subject a first dose of dulaglutide once weekly for a minimum of four weeks; and c) increasing the dose to a second dose administered once weekly, wherein the first dose is selected from the group consisting of 1.5 and 3.0 mg, and the second dose is selected from the group consisting of 3.0 and 4.5 mg.SELECTED DRAWING: None 【課題】２型糖尿病を治療するための、デュラグルチドの新用量を使用する方法を提供する。【解決手段】２型糖尿病（Ｔ２Ｄ）を有しかつ追加の血糖コントロールを必要とする対象において血糖コントロールを改善する方法であって、ａ）Ｔ２Ｄを有しかつさらなる血糖コントロールを必要とする対象を同定すること、ｂ）前記対象に週に１回の第１の用量のデュラグルチドを最低４週間投与すること、及びｃ）用量を週に１回投与される第２の用量に増加させること、を含み、前記第１の用量が１．５及び３．０ｍｇからなる群から選択され、かつ、前記第２の用量が３．０及び４．５ｍｇからなる群から選択される、方法である。【選択図】なし